If you have a true history of severe or active pancreatitis, retatrutide is not recommended
And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management
No h contraindicao formal, mas o uso de GLP-1 durante hormonioterapia (tamoxifeno ou inibidores de aromatase) deve ser acompanhado de perto pelo oncologista
This is the second pathway tirzepatide adds
Kooij, Derek IJsbrand Koster, Emma Eeltink, Mieneke Luijendijk, Lisa Drost, Fabien Ducrocq, Roger A.H
CrossRef Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway Jianping Zhu, Yuzhen Chen, Yidi Han, Ji Li, Fahrul Nurkolis PLOS One .2025